OSTAC® 520

Clodronat dinatri 520mg

Category:

Description

Clodronat dinatri 520mg

Osteolysis due to bone metastases of solid tumours (e.g. breast cancer, prostatic cancer) or due to haematological neoplasia (e.g. plasmocytoma).

Hypercalcaemia due to extended bone metastasis or due to bone destruction induced by malignant tumours without bone metastases.

Prevention of skeletal-related complications in adult patients with advanced cancer extended to the skeletal system.

OSTAC® 520